Immune Pharmaceuticals (IMNPQ) Short Interest Ratio & Short Volume

Short interest is the volume of Immune Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 100 shares of IMNPQ short. Learn More on Immune Pharmaceuticals' current short interest.

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($4.13 billion), Charter Communications, Inc. ($3.94 billion), Coinbase Global, Inc. ($2.38 billion), Lucid Group, Inc. ($2.30 billion), T. Rowe Price Group, Inc. ($2.22 billion), Williams-Sonoma, Inc. ($2.02 billion), Plug Power, Inc. ($1.94 billion), Chesapeake Energy Co. ($1.91 billion), Unity Software Inc. ($1.82 billion), and Rivian Automotive, Inc. ($1.74 billion). View all of the most shorted stocks.

Short selling IMNPQ is an investing strategy that aims to generate trading profit from Immune Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Immune Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMNPQ, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMNPQ, twice per month. The most recent reporting period available is August, 15 2022.